Lv4
460 积分 2022-02-22 加入
Analysis of CCND3 mutations in diffuse large B-cell lymphoma
3个月前
已完结
Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B‐Cell Lymphoma: A Real‐World, Multi‐Center, Retrospective Cohort Study
3个月前
已完结
Efflux of N1-acetylspermidine from hepatoma fosters macrophage-mediated immune suppression to dampen immunotherapeutic efficacy
6个月前
已完结
Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology
8个月前
已完结
Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma
8个月前
已完结
Primary Large B-cell Lymphomas of Immune-Privileged Sites
1年前
已完结
Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI
1年前
已完结
Maintenance Therapy in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma
1年前
已完结
The role of maintenance therapy in patients with diffuse large B cell lymphoma: A systematic review and meta-analysis
1年前
已完结
Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with de novo diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma
1年前
已完结
皖公网安备34019202002308
